Keeping Pace With The Evolving Global Landscape In Vaccine Development

Curious about how COVID-19 has impacted global drug developments and the regulatory landscape? Moderator Kari Abitbol, Director of Client Success at Endpoint News, carries a discussion on the evolving global landscape of vaccine development and the importance of keeping pace with the latest advancements in the field with life science experts:

• Sushant Sahastrabuddhe, Associate Director General, The International Vaccine Institute;
• Paul Griffin, Associate Professor, Infectious Diseases, Physician, Microbiologist, University of Queensland;
• Jennifer Arellano, Director of Clinical Services (Philippines), Novotech; and
• Babaji Yadav, Senior Consultant, Novotech Drug Development Consulting.

In this webinar, speakers highlight the key challenges and opportunities for vaccine development, including regulatory requirements, funding, and the need for innovative technologies. They also discuss how the COVID-19 pandemic has accelerated the development and approval of vaccines and how this experience can inform future vaccine development efforts.

Gain insight into the importance of collaboration and knowledge-sharing across the vaccine development community to maximize the impact of vaccine research and development efforts by accessing the full video